These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 874839)

  • 1. A novel effect of intrarenal infusion of a non-vasoconstrictor dose of noradrenaline on renal function: relationship to renal kallikrein and prostaglandin [proceedings].
    Mills IH; Obika LF
    J Physiol; 1977 May; 267(1):21P-22P. PubMed ID: 874839
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Effect of arterial infusion of prostaglandin E1 on the release of renal kallikrein.
    Obika LF; Mills IH
    J Endocrinol; 1976 Jun; 69(3):45P-46P. PubMed ID: 950539
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the natriuretic and kallikrein response to angiotensin by simultaneous intra-arterial infusion of noradrenaline in dogs [proceedings].
    Mills IH; Newport PA
    J Physiol; 1979 Apr; 289():70P-72P. PubMed ID: 458711
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between arterial pressure and vasoactive hormones in the release of renal kallikrein.
    Mills IH; Newport PA; Obika LF
    Adv Exp Med Biol; 1979; 120B():561-70. PubMed ID: 517250
    [No Abstract]   [Full Text] [Related]  

  • 5. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
    Susić H; Malik KU
    J Pharmacol Exp Ther; 1981 Nov; 219(2):377-82. PubMed ID: 6793715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.
    Susić H; Malik KU
    J Pharmacol Exp Ther; 1981 Sep; 218(3):588-92. PubMed ID: 6167710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of prostaglandins E, A and F on vasoconstrictor responses to norepinephrine, renal nerve stimulation and angiotensin in the feline kidney.
    Chapnick BM; Paustian PW; Klainer E; Joiner PD; Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1976 Jan; 196(1):44-52. PubMed ID: 1246015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
    Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
    Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The dependence of urinary kallikrein excretion on renal artery pressure.
    Bevan DR; Macfarlane NA; Mills IH
    J Physiol; 1974 Aug; 241(1):34P-35P. PubMed ID: 4419461
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of adrenergic neuroeffector events in the renal vasculature: role of prostaglandins.
    Malik KU; Susić H; Nasjletti A
    Prog Biochem Pharmacol; 1980; 17():108-15. PubMed ID: 7010365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release by vasopression of E-type prostaglandins from the rate kidney.
    Bell C; Mya MK
    Clin Sci Mol Med; 1977 Jan; 52(1):103-6. PubMed ID: 606458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of prostaglandin I2 from hog kidney by propranolol.
    Gotoh S; Ogihara T; Ohde H; Nakamaru M; Masuo K; Saeki S; Kumahara Y
    Prostaglandins Leukot Med; 1982 Jun; 8(6):537-44. PubMed ID: 7051046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal kallikrein: its localization and possible role in renal function.
    Carretero OA; Scicli AG
    Fed Proc; 1976 Feb; 35(2):194-8. PubMed ID: 1248653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary kallikrein excretion during bradykinin and eledoisin infusions and its relationship to urinary osmolality [proceedings].
    Mills IH; Obika LF
    J Physiol; 1977 Jul; 269(1):72P-73P. PubMed ID: 894582
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: The role of renal kallikrein in the excretion of water.
    Mills IH; Ward PE
    J Physiol; 1974 Jun; 239(2):123P-124P. PubMed ID: 4415307
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease in renal function due to sulphinpyrazone treatment early after myocardial infarction.
    Lijnen P; Boelaert J; van Eeghem P; Daneels R; Schurgers M; de Jaegere P; van der Stichele E; Vincke J; Fagard R; Verschueren LJ; Amery A
    Clin Nephrol; 1983 Mar; 19(3):143-6. PubMed ID: 6340878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Simultaneous increases in kallikrein in renal lymph and urine during saline infusion.
    de Bono E; Mills IH
    J Physiol; 1974 Sep; 241(2):127P-128P. PubMed ID: 4443916
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.
    Aiken JW; Vane JR
    J Pharmacol Exp Ther; 1973 Mar; 184(3):678-87. PubMed ID: 4347050
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: The diuretic and natriuretic effects of arterial infusions of substance P and their relationship to kallikrein excretion.
    Macfarlane NA; Mills IH; Ward PE
    J Physiol; 1974 May; 239(1):28P-30P. PubMed ID: 4853861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.